This content was created by Nick Norwitz. This content was uploaded by Nick Norwitz. This is a YouTube video titled "Ranking Heart Health Supplements (S to F-Tier)" (posted 2026-08-06T13:00:11Z) featuring Nick Norwitz presenting a solo, opinionated ranking of supplements for cardiovascular health. In a monologue he assigns tiers and gives brief rationales for omega-3s (A), TUDCA (B), nattokinase (S), red yeast rice (D), GLP-1 (B for indirect metabolic benefits), and microplastic‑binding probiotics (A), and invites viewer feedback. The excerpt is informational commentary about supplement efficacy, cardiovascular inflammation/plaque risk, and related research; thumbnail is provided in metadata.
Chapters
Ranking heart health supplements. All right, omega-3s, A tier. Omega-3s are critical for overall health and are definitely part of my health routine. They can help lower triglycerides, improve heart rate variability. The only reason I don't give them an S tier is because I think their biggest benefits are probably for the brain rather than the heart, although they're important for both. All right, next up, TUDCA. This is a very interesting bile acid supplement. It can help calm inflammation inside arteries, and there's some evidence it might help offset some of the negative effects of certain statins on GLP-1. I'm going to give it a B tier. Nattokinase. I do have to give this one S-tier. It appears to work through a variety of mechanisms, including lowering blood pressure, even in RCTs, and reducing inflammation. And some studies suggest it can reduce or reverse plaque in arteries. Now, the studies aren't perfect on plaque reversal, but I do think it's exciting enough that it does earn nattokinase the S-tier. All right, red yeast rice. The active compound in this is essentially a low-dose statin. D-tier. Not particularly interesting. GLP-1. For heart health specifically, I'm giving it a B-tier. I'm putting them there primarily because of their indirect benefits through improving obesity, insulin resistance, and metabolic health in the appropriate patients. All right, here's a wild card: microplastic-binding probiotics. I think some of the emerging literature on microplastics and cardiovascular disease is incredibly concerning, including studies in the New England Journal of Medicine, of all places, reporting that people with microplastics detected in their plaques have about a 4.5-fold higher risk of cardiovascular events. For that reason, I would give microplastic-binding probiotics an A tier. What do you think I missed?
